These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6118399)

  • 1. Slow-reacting substances from rat leukocytes: selective action on the airways, and progress toward elucidation of their structure.
    Bach MK; Brashler JR; Johnson MA; Drazen JM
    Kroc Found Ser; 1981; 14():37-50. PubMed ID: 6118399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on slow reacting substance (SRS). Comparison of naturally occurring, radiolabeled SRS and synthetic leukotriene D4 (LTD4) on high performance liquid chromatography, and of partially purified SRS-A and LTD4 on the activity of smooth muscle preparations of guinea pig].
    Watanabe-Kohno S; Kiso S; Ohata K
    Arerugi; 1983 Jan; 32(1):46-56. PubMed ID: 6134518
    [No Abstract]   [Full Text] [Related]  

  • 3. SRS-A and other mediators. Slow reacting substance biosynthesis, characterization and purification.
    Yecies LD; Parker CW
    Monogr Allergy; 1979; 14():155-62. PubMed ID: 41174
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandins and slow-reacting substance.
    Parker CW
    J Allergy Clin Immunol; 1979 Jan; 63(1):1-14. PubMed ID: 82564
    [No Abstract]   [Full Text] [Related]  

  • 5. Two rat mononuclear cell-derived slow reacting substances: kinetic evidence that the peripheral airways-selective spasmogen is derived from a nonselectively acting precursor.
    Bach MK; Brashler JR; Johnson MA; Drazen JM
    Immunopharmacology; 1980 Dec; 2(4):361-73. PubMed ID: 6109699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and purification of slow-reacting substance (SRS) from RBL-1 cells.
    Parker CW; Falkenhein SF; Huber MM
    Methods Enzymol; 1982; 86():416-26. PubMed ID: 6127597
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of sodium on the biological activity of slow-reacting substances.
    Tsai JJ; Wang SR
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):8-14. PubMed ID: 2863094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure elucidation and biosynthesis of slow reacting substances and slow reacting substance of anaphylaxis from guinea pig and human lung.
    Morris HR; Taylor GW; Jones CM; Scully N; Piper PJ; Tippins JR; Samhoun MN
    Prog Lipid Res; 1981; 20():719-25. PubMed ID: 6123115
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of leukotriene biosynthesis by acetylenic analogs.
    Sok DE; Han CQ; Pai JK; Sih CJ
    Biochem Biophys Res Commun; 1982 Jul; 107(1):101-8. PubMed ID: 6127073
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure, function, and metabolism of leukotriene constituents of SRS-A.
    Lewis RA; Austen KF; Drazen JM; Soter NA; Figueiredo JC; Corey EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():137-51. PubMed ID: 6211948
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow-reacting substances of anaphylaxis--a commentary.
    Brokelhurst W
    Agents Actions Suppl; 1979; (6):37. PubMed ID: 43081
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of the tracheal and lung parenchymal effects of synthetic leukotrienes in the guinea pig.
    Wasserman MA; Weichman BM; Woodward DF; Muccitelli RM; Gleason JG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():133-7. PubMed ID: 6303081
    [No Abstract]   [Full Text] [Related]  

  • 13. Production of slow reacting substance in rat granulomatous inflammation.
    Koshihara Y; Nagasaki I; Murota S
    Biochem Pharmacol; 1981 Jul; 30(13):1781-4. PubMed ID: 6115650
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the actions of leukotriene E4 with those of leukotrienes B4, C4, and D4 on guinea pig lung and ileal smooth muscle in vitro.
    Piper PJ; Samhoun MN
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():127-31. PubMed ID: 6303079
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic characterization of slow-reacting substances.
    Parker CW; Huber MM; Falkenhein SF
    Methods Enzymol; 1982; 86():655-67. PubMed ID: 6127599
    [No Abstract]   [Full Text] [Related]  

  • 16. The leukotrienes: an introduction.
    Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():1-17. PubMed ID: 6124094
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity.
    Parker CW; Huber MM; Hoffman MK; Falkenhein SF
    Prostaglandins; 1979 Nov; 18(5):673-86. PubMed ID: 44377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and spectrum of pharmacologic action of aryl-arylamino- and aryl-aryliminoacetonitriles].
    Barnikow G; Hagen A; Hagen V; Göres E; Richter D; Fichtner K
    Pharmazie; 1983 Jul; 38(7):449-52. PubMed ID: 6634911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family of calcium ionophore-induced slow reacting substances produced by rat mononuclear cells: enhancement of production with different mercaptans results in formation of different products.
    Bach MK; Brashler JR
    Int J Immunopharmacol; 1979; 1(3):205-11. PubMed ID: 45182
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.
    Fleisch JH; Haisch KD; Spaethe SM; Rinkema LE; Cullinan GJ; Schmidt MJ; Marshall WS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):681-9. PubMed ID: 6202867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.